Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Diagnos Inc V.ADK

Alternate Symbol(s):  DGNOF

Diagnos Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications, such as computer assisted retina analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time screening of large volumes of patients. It provides software-based services to assist health specialists in the detection of diabetic retinopathy and other eye-related pathologies. Its geographical areas include Canada, the United States of America, Mexico, and Chile. The Company’s subsidiaries include Diagnos Internacional SA de CV and Diagnos Healthcare (India) Private Limited.


TSXV:ADK - Post by User

Bullboard Posts
Comment by u2bobon Dec 13, 2017 8:13am
97 Views
Post# 27144680

RE:RE:RE:Diagnos will get contract in Brazil in the coming weeks!

RE:RE:RE:Diagnos will get contract in Brazil in the coming weeks!
Caritas3 wrote: U2Bob. Yes...Brazil is a real possibility for a contract 
for Diagnos. That would be great;However, does ADK
have the capacity to fulfill the contracts on a timely basis?
Seems to me...ADK is having some difficulties meeting
current obligations.  


I look at it this way ...the company is gaining experience every day that passes...so when implementing another contract such as the Mexican one... management will be able to apply the same... and or even better logistics and personal to improve on what we are bringing to our customers ...this experience will be invaluable to Diagnos moving forward on growth curve...I think if people take the time and go over the last years NR`S since the Bayer announcement you can see the company is moving forward in a precise step by step growth pattern ....many penny flippers can`t wait... so they will try and flip... and t hedge there bets ! All I can say is good luck...

One thing I would say about the big boys Google IBM and the others...is they are all over the place and can`t seem to stay focused on one sector of AI... they are to busy trying to out do each other in every sector...If there is one thing I could see us doing as we grow... is maybe partner with  Medical Imaging Equipment Supplier ...for a couple reasons it could be a win win they use our FDA approved AI software and Deep Learnig platform to grow our buisness and theres...good selling feature for both software developer and Equipment supplier... to be the first to market...

Nothing I have heard on this thread would make me want to sell out ..when looking at risk vs. reward ...only real question is how you get there !

Later...
Bob

Bullboard Posts